AVITA Medical to Host Investor Webinar Briefing
December 04, 2023 09:00 ET
|
AVITA Medical
AVITA Medical to host investor webinar briefing on December 5, 2023, at 2:00 p.m. PST. Register at https://rebrand.ly/Dec2023webinar
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023 16:15 ET
|
AVITA Medical
VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Updates Full Year 2023 Guidance
November 20, 2023 16:15 ET
|
AVITA Medical
VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
November 09, 2023 16:01 ET
|
AVITA Medical
VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
November 09, 2023 09:00 ET
|
AVITA Medical
AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations, to strategically expand its global presence to Europe.
AVITA Medical to Announce Third Quarter 2023 Financial Results
October 19, 2023 16:05 ET
|
AVITA Medical
VALENCIA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives
October 18, 2023 09:00 ET
|
AVITA Medical
AVITA Medical announces third quarter 2023 preliminary commercial revenue of $13.5 million and secures up to $90 million of non-dilutive debt financing.
AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma
September 25, 2023 08:00 ET
|
AVITA Medical
VALENCIA, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical to Present at the Cantor Global Healthcare Conference
September 21, 2023 16:30 ET
|
AVITA Medical
VALENCIA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical to Participate in Upcoming Investor Conferences
September 06, 2023 18:45 ET
|
AVITA Medical
VALENCIA, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...